細胞和基因供應鏈服務市場－全球產業規模、佔有率、趨勢、機會和預測，按技術、應用、最終用戶地區和競爭格局分類，2020-2030年預測

2024年全球細胞和基因供應鏈服務市場規模為14.4億美元，預計2030年將以9.85%的複合年成長率成長至25.3億美元。該市場涵蓋運輸敏感細胞和基因療法所需的專業物流、處理和受控存儲，確保從患者樣本採集到給藥的整個過程中產品的完整性。市場成長的主要驅動力是越來越多的此類先進療法進入臨床試驗並獲得監管部門批准，以及生物製藥創新領域的大量投資。

主要市場促進因素

細胞和基因治療技術的進步顯著影響供應鏈服務市場，帶來了新的物流複雜性。基因編輯工具和先進遞送系統的演進使得精準的基因修飾和更廣泛的治療應用成為可能，這需要高度專業的冷鏈管理和運輸。

主要市場挑戰

建立和維護穩健的全球一體化低溫物流基礎設施的複雜要求，對全球細胞和基因供應鏈服務市場構成了重大障礙。這些先進療法需要超低溫儲存和精確、不間斷的溫控運輸，以確保從患者樣本採集到最終給藥的整個過程中產品的完整性。

主要市場趨勢

增強型數位化追溯和供應鏈最佳化著重於利用先進技術，實現整個供應鏈的即時可視性和控制。鑑於細胞和基因療法的個人化和時效性，從患者樣本採集到給藥的整個過程中，對物料進行精確追蹤對於維護產品完整性和患者安全至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球細胞與基因供應鏈服務市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按技術（雲端部署、本地部署）
  • 依應用領域（訂購及安排、樣本採集、物流、治療後追蹤）
  • 依最終使用者分類（生物樣本庫/細胞庫、醫院、研究機構、細胞治療實驗室、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美細胞與基因供應鏈服務市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲細胞與基因供應鏈服務市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區細胞與基因供應鏈服務市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲細胞與基因供應鏈服務市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美細胞與基因供應鏈服務市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球細胞與基因供應鏈服務市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Biocair International Limited
• Arvato SE
• Associated Couriers, LLC.
• TrakCel Limited
• Parkoursc Inc.
• DHL
• McKesson Corporation
• Almac Group Limited
• Catalent Inc.
• Biostor Ltd.

第16章：策略建議

第17章調查會社について,免責事項

The Global Cell and Gene Supply Chain Services Market , valued at USD 1.44 Billion in 2024, is projected to experience a CAGR of 9.85% to reach USD 2.53 Billion by 2030. The Global Cell and Gene Supply Chain Services Market involves the specialized logistics, handling, and controlled storage necessary for transporting sensitive cell and gene therapies, ensuring product integrity from patient sample collection through to administration. The market's growth is predominantly supported by the increasing number of these advanced therapies progressing through clinical trials and receiving regulatory approvals, coupled with significant investments in biopharmaceutical innovation.

Key Market Drivers

Advancements in cell and gene therapy technologies significantly influence the supply chain services market by introducing novel logistical complexities. The evolution of gene editing tools and advanced delivery systems enables precise genetic modifications and expanded therapeutic applications, necessitating highly specialized cold chain management and transport.

Key Market Challenges

The intricate requirement for establishing and maintaining a robust, globally integrated cryogenic logistics infrastructure presents a significant impediment to the Global Cell and Gene Supply Chain Services Market. These advanced therapies demand ultra-cold storage and precise, uninterrupted temperature-controlled transportation to preserve product integrity from patient sample collection through final administration. The technical complexity and specialized equipment necessary for such rigorous cold chain management across diverse geographic regions create substantial operational hurdles for service providers.

Key Market Trends

Enhanced Digital Traceability and Supply Chain Optimization focuses on leveraging advanced technologies to achieve real-time visibility and control across the entire supply chain. Given the personalized and time-sensitive nature of cell and gene therapies, accurate tracking of materials from patient sample collection to administration is paramount for maintaining product integrity and patient safety. Digitalization and real-time tracking technologies can significantly minimize supply chain risks by enhancing product visibility throughout the value chain.

Key Market Players

• Biocair International Limited
• Arvato SE
• Associated Couriers, LLC.
• TrakCel Limited
• Parkoursc Inc.
• DHL
• McKesson Corporation
• Almac Group Limited
• Catalent Inc.
• Biostor Ltd.

Report Scope:

In this report, the Global Cell and Gene Supply Chain Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell and Gene Supply Chain Services Market , By Technology:

• Presence on cloud
• Presence on-premises

Cell and Gene Supply Chain Services Market , By Applications:

• Ordering and scheduling
• Sample collection
• Logistics
• Post treatment follow-up

Cell and Gene Supply Chain Services Market , By End-User:

• Biobank/ cell-bank
• Hospitals
• Research institutes
• Cell therapy labs
• Others

Cell and Gene Supply Chain Services Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell and Gene Supply Chain Services Market .

Available Customizations:

Global Cell and Gene Supply Chain Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell and Gene Supply Chain Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Presence on cloud, Presence on-premises)
  • 5.2.2. By Applications (Ordering and scheduling, Sample collection, Logistics, Post treatment follow-up)
  • 5.2.3. By End-User (Biobank/ cell-bank, Hospitals, Research institutes, Cell therapy labs, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Cell and Gene Supply Chain Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Applications
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell and Gene Supply Chain Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Applications
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Cell and Gene Supply Chain Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Applications
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Cell and Gene Supply Chain Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Applications
      • 6.3.3.2.3. By End-User

7. Europe Cell and Gene Supply Chain Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Applications
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell and Gene Supply Chain Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Applications
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Cell and Gene Supply Chain Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Applications
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Cell and Gene Supply Chain Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Applications
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Cell and Gene Supply Chain Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Applications
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Cell and Gene Supply Chain Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Applications
      • 7.3.5.2.3. By End-User

8. Asia Pacific Cell and Gene Supply Chain Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Applications
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell and Gene Supply Chain Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Applications
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Cell and Gene Supply Chain Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Applications
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Cell and Gene Supply Chain Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Applications
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Cell and Gene Supply Chain Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Applications
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Cell and Gene Supply Chain Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Applications
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Cell and Gene Supply Chain Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Applications
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cell and Gene Supply Chain Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Applications
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Cell and Gene Supply Chain Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Applications
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Cell and Gene Supply Chain Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Applications
      • 9.3.3.2.3. By End-User

10. South America Cell and Gene Supply Chain Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Applications
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell and Gene Supply Chain Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Applications
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Cell and Gene Supply Chain Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Applications
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Cell and Gene Supply Chain Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Applications
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cell and Gene Supply Chain Services Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Biocair International Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Arvato SE
• 15.3. Associated Couriers, LLC.
• 15.4. TrakCel Limited
• 15.5. Parkoursc Inc.
• 15.6. DHL
• 15.7. McKesson Corporation
• 15.8. Almac Group Limited
• 15.9. Catalent Inc.
• 15.10. Biostor Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer